Unknown PHASE2 INTERVENTIONAL 3-arm NCT02883023

Electrosclerotherapy for Capillary Malformations

Electrosclerotherapy as a Novel Treatment Option for Capillary Malformations: A Pilot Study

Sponsor: IGEA

Conditions Capillary Malformations Vascular Malformations

Interventions Electrosclerotherapy Intralesional bleomycin injection

Updated 8 times since 2017 Last updated: Jun 26, 2017 Started: Nov 30, 2016 Primary completion: Jan 31, 2018 Completion: Mar 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02883023, this PHASE2 trial focuses on Capillary Malformations and Vascular Malformations and remains ongoing. Sponsored by IGEA, it has been updated 8 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jul 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jun 2018 — Jul 2019 [monthly]

Recruiting PHASE2

▶ Show 3 earlier versions

Jul 2017 — Jun 2018 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Feb 2017 — Jul 2017 [monthly]

Not Yet Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE2

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IGEA
Sophie Horbach

Data source: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Amsterdam, Netherlands